Evidence map›Paper›PMID 25229819›Full record

ArticlePloS one2014

Evidence for fibroblast growth factor-2 as a mediator of amphetamine-enhanced motor improvement following stroke.

William A Wolf, Jody L Martin, Gwendolyn L Kartje, Robert G Farrer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

William A WolfResearch Service, Edward Hines, Jr. Veterans Administration Hospital, Hines, Illinois, United States of America; Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Jody L MartinDepartment of Cell and Molecular Physiology, Loyola University, Maywood, Illinois, United States of America.
Gwendolyn L KartjeResearch Service, Edward Hines, Jr. Veterans Administration Hospital, Hines, Illinois, United States of America; Neurology Service, Edward Hines, Jr. Veterans Administration Hospital, Hines, Illinois, United States of America; Department of Molecular Pharmacology and Therapeutics, Loyola University, Maywood, Illinois, United States of America.
Robert G FarrerResearch Service, Edward Hines, Jr. Veterans Administration Hospital, Hines, Illinois, United States of America; Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois, United States of America.
University of Illinois Chicago · USEdward Hines, Jr. VA Hospital · USLoyola University Chicago · US

Funding

Drug-Enhanced Rehabilitation in Recovery from StrokeR01HD044772 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WOLF, WILLIAM A. · 2003 to 2007
$1.5M
NICHD NIH HHS HD 44772NICHD NIH HHS R01 HD044772
6 · The paper itself

Abstract

Previously we have shown that addition of amphetamine to physical therapy results in enhanced motor improvement following stroke in rats, which was associated with the formation of new motor pathways from cortical projection neurons of the contralesional cortex. It is unclear what mechanisms are involved, but amphetamine is known to induce the neuronal release of catecholamines as well as upregulate fibroblast growth factor-2 (FGF-2) expression in the brain. Since FGF-2 has been widely documented to stimulate neurite outgrowth, the present studies were undertaken to provide evidence for FGF-2 as a neurobiological mechanism underlying amphetamine-induced neuroplasticity. In the present study rats that received amphetamine plus physical therapy following permanent middle cerebral artery occlusion exhibited significantly greater motor improvement over animals receiving physical therapy alone. Amphetamine plus physical therapy also significantly increased the number of FGF-2 expressing pyramidal neurons of the contralesional cortex at 2 weeks post-stroke and resulted in significant axonal outgrowth from these neurons at 8 weeks post-stroke. Since amphetamine is a known releaser of norepinephrine, in vitro analyses focused on whether noradrenergic stimulation could lead to neurite outgrowth in a manner requiring FGF-2 activity. Primary cortical neurons did not respond to direct stimulation by norepinephrine or amphetamine with increased neurite outgrowth. However, conditioned media from astrocytes exposed to norepinephrine or isoproterenol (a beta adrenergic agonist) significantly increased neurite outgrowth when applied to neuronal cultures. Adrenergic agonists also upregulated FGF-2 expression in astrocytes. Pharmacological analysis indicated that beta receptors and alpha1, but not alpha2, receptors were involved in both effects. Antibody neutralization studies demonstrated that FGF-2 was a critical contributor to neurite outgrowth induced by astrocyte-conditioned media. Taken together the present results suggest that noradrenergic activation, when combined with physical therapy, can improve motor recovery following ischemic damage by stimulating the formation of new neural pathways in an FGF-2-dependent manner.

Indexed as

Adrenergic AgonistsAmphetamineAnimalsAxonsFibroblast Growth Factor 2MaleMotor ActivityNeuritesPyramidal CellsRatsReceptors, Adrenergic, alpha-1Recovery of FunctionStrokeTime FactorsUp-RegulationAdrenergic AgonistsAmphetamineFibroblast Growth Factor 2Receptors, Adrenergic, alpha-1

Identifiers

PMID25229819
PMCPMC4168218
OpenAlexW1975949921

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.